This Article Full Text Full Text (PDF) Supplementary Data Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Shidara, Y. Articles by Ohta, S. Search for Related Content PubMed PubMed Citation Articles by Shidara, Y. Articles by Ohta, S.

Positive Contribution of Pathogenic Mutations in the Mitochondrial Genome to the Promotion of Cancer by Prevention from Apoptosis

Departments of ¹ Pathology and ² Pediatrics, Tokyo Women's Medical University, School of Medicine, Tokyo, Japan; ³ Department of Biochemistry and Cell Biology, Institute of Development and Aging Sciences, Graduate School of Medicine, Nippon Medical School, Kawasaki, Japan; and ⁴ Department of Neurology and Neuroscience, Weill Medical College of Cornell University, New York, New York

Requests for reprints: Shigeo Ohta, Department of Biochemistry and Cell Biology, Institute of Development and Aging Sciences, Graduate School of Medicine, Nippon Medical School, Kosugi-cho, Nakahara-ku, Kawasaki, 211-8533, Japan. Phone: 81-44-733-9267; Fax: 81-44-733-9268; E-mail: ohta{at}nms.ac.jp.

The role of mitochondrial dysfunction in cancer has been a subject of great interest and much ongoing investigation. Although most cancer cells harbor somatic mutations in mitochondrial DNA (mtDNA), the question of whether such mutations contribute to the promotion of carcinomas remains unsolved. Here we used trans-mitochondrial hybrids (cybrids) containing a common HeLa nucleus and mtDNA of interest to compare the role of mtDNA against the common nuclear background. We constructed cybrids with or without a homoplasmic pathogenic point mutation at nucleotide position 8,993 or 9,176 in the mtDNA ATP synthase subunit 6 gene (MTATP6) derived from patients with mitochondrial encephalomyopathy. When the cybrids were transplanted into nude mice, the MTATP6 mutations conferred an advantage in the early stage of tumor growth. The mutant cybrids also increased faster than wild type in culture. To complement the mtDNA mutations, we transfected a wild-type nuclear version of MTATP, whose codons were converted to the universal genetic codes containing a mitochondrial target sequence, into the nucleus of cybrids carrying mutant MTATP6. The restoration of MTATP slowed down the growth of tumor in transplantation. Conversely, expression of a mutant nuclear version of MTATP6 in the wild-type cybrids declined respiration and accelerated the tumor growth. These findings showed that the advantage in tumor growth depended upon the MTATP6 function but was not due to secondary nuclear mutations caused by the mutant mitochondria. Because apoptosis occurred less frequently in the mutant versus wild-type cybrids in cultures and tumors, the pathogenic mtDNA mutations seem to promote tumors by preventing apoptosis.

Key Words: ATP synthase • cybrid • mitochondrial encephalomyopathy • transplantation • nude mice

This article has been cited by other articles:

				M. Guha, H. Pan, J.-K. Fang, and N. G. Avadhani Heterogeneous Nuclear Ribonucleoprotein A2 Is a Common Transcriptional Coactivator in the Nuclear Transcription Response to Mitochondrial Respiratory Stress Mol. Biol. Cell, September 15, 2009; 20(18): 4107 - 4119. [Abstract] [Full Text] [PDF]

				J. S. Park, L. K. Sharma, H. Li, R. Xiang, D. Holstein, J. Wu, J. Lechleiter, S. L. Naylor, J. J. Deng, J. Lu, et al. A heteroplasmic, not homoplasmic, mitochondrial DNA mutation promotes tumorigenesis via alteration in reactive oxygen species generation and apoptosis Hum. Mol. Genet., May 1, 2009; 18(9): 1578 - 1589. [Abstract] [Full Text] [PDF]

				L.-F. Dong, R. Freeman, J. Liu, R. Zobalova, A. Marin-Hernandez, M. Stantic, J. Rohlena, K. Valis, S. Rodriguez-Enriquez, B. Butcher, et al. Suppression of Tumor Growth In vivo by the Mitocan {alpha}-tocopheryl Succinate Requires Respiratory Complex II Clin. Cancer Res., March 1, 2009; 15(5): 1593 - 1600. [Abstract] [Full Text] [PDF]

				G. Biswas, W. Tang, N. Sondheimer, M. Guha, S. Bansal, and N. G. Avadhani A Distinctive Physiological Role for I{kappa}B{beta} in the Propagation of Mitochondrial Respiratory Stress Signaling J. Biol. Chem., May 2, 2008; 283(18): 12586 - 12594. [Abstract] [Full Text] [PDF]

				K. Ishikawa, K. Takenaga, M. Akimoto, N. Koshikawa, A. Yamaguchi, H. Imanishi, K. Nakada, Y. Honma, and J.-I. Hayashi ROS-Generating Mitochondrial DNA Mutations Can Regulate Tumor Cell Metastasis Science, May 2, 2008; 320(5876): 661 - 664. [Abstract] [Full Text] [PDF]

				J. A. Mayr, D. Meierhofer, F. Zimmermann, R. Feichtinger, C. Kogler, M. Ratschek, N. Schmeller, W. Sperl, and B. Kofler Loss of Complex I due to Mitochondrial DNA Mutations in Renal Oncocytoma Clin. Cancer Res., April 15, 2008; 14(8): 2270 - 2275. [Abstract] [Full Text] [PDF]

				M. Guha, S. Srinivasan, G. Biswas, and N. G. Avadhani Activation of a Novel Calcineurin-mediated Insulin-like Growth Factor-1 Receptor Pathway, Altered Metabolism, and Tumor Cell Invasion in Cells Subjected to Mitochondrial Respiratory Stress J. Biol. Chem., May 11, 2007; 282(19): 14536 - 14546. [Abstract] [Full Text] [PDF]

				S. Srivastava, J. N. Barrett, and C. T. Moraes PGC-1{alpha}/{beta} upregulation is associated with improved oxidative phosphorylation in cells harboring nonsense mtDNA mutations Hum. Mol. Genet., April 15, 2007; 16(8): 993 - 1005. [Abstract] [Full Text] [PDF]

				Y.-G. Yao, Y. Ogasawara, S. Kajigaya, J. J. Molldrem, R. P. Falcao, M.-C. Pintao, J. P. McCoy Jr, E. G. Rizzatti, and N. S. Young Mitochondrial DNA sequence variation in single cells from leukemia patients Blood, January 15, 2007; 109(2): 756 - 762. [Abstract] [Full Text] [PDF]

				G. J. Kim, G. M. Fiskum, and W. F. Morgan A Role for Mitochondrial Dysfunction in Perpetuating Radiation-Induced Genomic Instability Cancer Res., November 1, 2006; 66(21): 10377 - 10383. [Abstract] [Full Text] [PDF]

				G. J.Kim, K. Chandrasekaran, and W. F.Morgan Mitochondrial dysfunction, persistently elevated levels of reactive oxygen species and radiation-induced genomic instability: a review Mutagenesis, November 1, 2006; 21(6): 361 - 367. [Abstract] [Full Text] [PDF]

				S. Zhou, K. Kassauei, D. J. Cutler, G. C. Kennedy, D. Sidransky, A. Maitra, and J. Califano An Oligonucleotide Microarray for High-Throughput Sequencing of the Mitochondrial Genome J. Mol. Diagn., September 1, 2006; 8(4): 476 - 482. [Abstract] [Full Text] [PDF]

				G. C. Kujoth, C. Leeuwenburgh, and T. A. Prolla Mitochondrial DNA mutations and apoptosis in Mammalian aging. Cancer Res., August 1, 2006; 66(15): 7386 - 7389. [Abstract] [Full Text] [PDF]

				D. Chen, Z. Yu, Z. Zhu, and C. D. Lopez The p53 Pathway Promotes Efficient Mitochondrial DNA Base Excision Repair in Colorectal Cancer Cells. Cancer Res., April 1, 2006; 66(7): 3485 - 3494. [Abstract] [Full Text] [PDF]

				C. van Waveren, Y. Sun, H. S. Cheung, and C. T. Moraes Oxidative phosphorylation dysfunction modulates expression of extracellular matrix--remodeling genes and invasion Carcinogenesis, March 1, 2006; 27(3): 409 - 418. [Abstract] [Full Text] [PDF]

				A. Isidoro, E. Casado, A. Redondo, P. Acebo, E. Espinosa, A. M. Alonso, P. Cejas, D. Hardisson, J. A. Fresno Vara, C. Belda-Iniesta, et al. Breast carcinomas fulfill the Warburg hypothesis and provide metabolic markers of cancer prognosis Carcinogenesis, December 1, 2005; 26(12): 2095 - 2104. [Abstract] [Full Text] [PDF]